Live Breaking News & Updates on Deepak sapra

Stay informed with the latest breaking news from Deepak sapra on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Deepak sapra and stay connected to the pulse of your community

Sputnik vaccine priced at Rs 995 per dose in India, first shot administered by Dr Reddy's in Hyderabad

The soft launch of the Covid vaccine Sputnik V has commenced and the first dose of the vaccine was administered in Hyderabad, the drug firm said in a statement on Friday.
First doses of Sputnik V administered in India. Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy's Laboratories receives the first jab of the vaccine in Hyderabad: Sputnik V#COVID19pic.twitter.com/95eOT6gGWR
The first consignment of imported doses of the Sputnik V vaccine landed in India on May 1, and received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13, 2021, it added.
"Further consignments of imported doses are expected over the upcoming months. Subsequently, supply of the Sputnik V vaccine will commence from Indian manufacturing partners," it added.

India , Serbia , Honduras , Kazakhstan , Mongolia , Belarus , Moldova , Mauritius , Angola , Syria , Russia , Sri-lanka

Sputnik V vaccine priced at Rs 995 per dose in India, first shot administered by Dr Reddy's in Hyderabad

Sputnik V vaccine priced at Rs 995 per dose in India, first shot administered by Dr Reddy's in Hyderabad
India Today Web Desk
One dose of imported Sputnik V Covid-19 vaccine will cost Rs 995.40 in India, drug firm Dr Reddy's Laboratories said on Friday. Doses of Sputnik V Covid-19 vaccine that will be made in India, however, may be cheaper.
The imported doses of the vaccine are presently priced at a maximum retail price of Rs 948, with 5 per cent GST per dose, with the possibility of a lower price point when local supply begins, Dr Reddy's Laboratories added.
The soft launch of the Covid vaccine Sputnik V has commenced and the first dose of the vaccine was administered in Hyderabad, the drug firm said in a statement on Friday.

India , Serbia , Honduras , Kazakhstan , Mongolia , Belarus , Moldova , Mauritius , Angola , Syria , Russia , Sri-lanka

First jab of Sputnik V COVID-19 vaccine administered; to cost around Rs 1,000

Toggle navigation
Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy's Laboratories receives the first jab of the vaccine in Hyderabad.
First jab of Sputnik V COVID-19 vaccine administered; to cost around Rs 1,000
ANI |
Updated: May 14, 2021 14:35 IST
Hyderabad (Telangana) [India], May 14 (ANI): With the Sputnik VCOVID-19 vaccine receiving clearance in India, Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy's Laboratories received the first jab of the vaccine in Hyderabad.
The first consignment of imported doses of Sputnik V vaccine landed in India on May 1 received regulatory clearance from the Central Drugs Laboratory at Kasauli in Himachal Pradesh on May 13.

Hyderabad , Andhra-pradesh , India , Himachal-pradesh , Kasauli , Deepak-sapra , Central-drugs-laboratory-at-kasauli , Global-head , Custom-pharma-services , Central-drugs-laboratory , Covid-19 , Oronavirus

Dr. Reddy's Announces Imported Sputnik V Price in India: Check Vaccine Cost

Dr. Reddy's Announces Imported Sputnik V Price in India: Check Vaccine Cost
May 14, 2021, 13:41 IST
Sputnik-V, Russia’s COVID vaccine will soon be available in India with Dr Reddy’s Laboratories taking up the manufacturing of the vaccine.
The company fixed the cost at Rs 995.40 per dose inclusive of 5 per cent GST. It is likely to become cheaper after its introduction in the market.
Sputnik V, which has an efficiency of 91.6 per cent, is the third vaccine to be approved for use in India.
Dr Reddy's administered the first dose of the vaccine in Hyderabad today as part of a limited pilot soft launch. Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy's Laboratories receives the first jab of the vaccine in Hyderabad.

Hyderabad , Andhra-pradesh , India , Deepak-sapra , Pfizer , Global-head-of-custom-pharma-services , Global-head , Custom-pharma-services , Sputnikv-in-india , Putnikv-india-rate , Putnik-vaccine-india-rate , Putnik-vaccine-by-dr-reddys

Sputnik V Vaccine India - Your Questions About Newest COVID-19 Shot Answered

Sputnik V COVID-19 vaccines were developed by Russia's Gamaleya Research Institute.
New Delhi:
The first doses of Russia's Sputnik V COVID-19 vaccine were administered in India on Friday in a soft launch that is expected to be scaled up in the coming days. The vaccine will cost Rs 995.40 including tax for a shot, the company said, as well as announcing a single-dose variant Sputnik Light that could be approved in the next few weeks. Deepak Sapra, the CEO of APIs and Services at Dr Reddy's Laboratories, which is manufacturing the vaccines in India, spoke to NDTV in an exclusive interview, answering a host of questions from viewers.

India , Russia , Russian , Deepak-sapra , Aarogya-setu , Russia-gamaleya-research-institute , Gamaleya-research-institute-of-epidemiology , Sputnik-light , Gamaleya-research-institute , Gamaleya-research , Sputnikv-vaccine , Covid-19-vaccine

250 Million Sputnik Doses For India in 8-10 Months, Efficacy Against Variants Being Tested: Dr Reddy's Executive

250 Million Sputnik Doses For India in 8-10 Months, Efficacy Against Variants Being Tested: Dr Reddy's Executive
News18
2 hours ago
Marya Shakil
© Provided by News18
250 Million Sputnik Doses For India in 8-10 Months, Efficacy Against Variants Being Tested: Dr Reddy's Executive
India will receive a total of 250 million doses of Russia’s Sputnik V over the next 8-10 months and its production here is expected to begin from July, a top executive at Dr Reddy’s, the local partner for the vaccine against Covid-19, said on Friday. The vaccine by Russia’s Gamaleya Institute is priced at Rs 948; its retail price of Sputnik V will be Rs 995.40 a dose with 5% GST. “The price which has been announced is Rs 948 plus GST for the imported dosages. Once we have the India-manufactured product available, the pricing for the vaccine will be different. We do not have a figure currently. We are working out the best possible ways to minimise the number so that it is accessible to as many Indians as possible,” Deepak Sapra, CEO, API & Services at Dr Reddy’s, told CNN-News18 in an exclusive interview. Dr Reddy’s Laboratories soft-launched Sputnik V in India on Friday with imported doses, as Sapra took the first shot in Hyderabad. Asked if the price of the vaccine will be different for the Centre and states — and what the price for private hospitals will be — Sapra said, “That is a discussion we are going to have. We are going to take guidance of the various stakeholders involved, including the government and the Niti Aayog. And based on that, we will be determining what is the best possible way to maximise access.” Replying to a question on Sputnik V’s efficacy against variants of Sars-Cov-2 (the virus the causes Covid-19), he said, “Sputnik V has been tested on some of the variants. The variant on which we have received the data from our Russian partner is the UK variant. Testing is underway on the South African variant.” “Now we have two large categories of variants — the double variant which has been found in India and the triple mutant. In addition to the efforts being taken by our Russian partner, we are working very closely with the department of biotechnology and also the National Institute of Virology to test Sputnik V on the variants. All of this testing is at different stages. We expect that by the end of May or early June, we will have credible data from Sputnik on these variants in addition to the data we already have,” he said. A new Lancet report has raised questions over the interim results of the Phase III trials of Sputnik V. Addressing the concerns raised, Sapra said: “After the Lancet journal published those observations, they were studied, and our partner, the Gamaleya Institute of Epidemiology in Russia, has come up with the response to those.” Assuring that the vaccine is safe and effective, he said, “We have clinical data on subjects in India which was very consistent with what was reported by our Russian partners in Lancet. We also have real world data on several million subjects all over the world, which has also demonstrated a very high level of consistency with what was originally reported. So, we feel comfortable that it is a safe, secure, immunogenic and efficacious vaccine.” The first consignment of imported doses of the Sputnik V vaccine from Russian Direct Investment Fund (RDIF) landed in India on May 1 after regulatory clearance from the Central Drugs Laboratory. RDIF has tie-ups with six Indian drug firms to manufacture the vaccine. Two other vaccines — Covaxin by Bharat Biotech and Serum Institute’s Covishield — currently used in the vaccination programme across the country are priced at Rs 1,200 and Rs 600 per dose, respectively, at private hospitals. “Local manufacturing is expected to give us the vaccine for commercial usage from July time frame.. after that it will steadily ramp up over the next few months,” Sapra said. He said the company would initially be looking tentatively at 35 cities, where cold chain facilities are available for launching the product and expand based on the infrastructure. Sputnik V needs to be stored at -18 degrees centigrade, Sapra said. On another vaccine, Sputnik Light from RDIF, Sapra said the Russian organisation had submitted to Dr Reddy’s the interim results of the single-dose vaccine’s trials — which are being studied. As soon as the vaccine completes the 42-day trial, Dr Reddy’s would approach the Indian regulators for necessary approvals.

South-africa , Hyderabad , Andhra-pradesh , India , United-kingdom , Russia , Russian , South-african , Bharat , Deepak-sapra , Serum-institute-covishield , Gamaleya-institute-of-epidemiology

250 Million Sputnik Doses For India in 8-10 Months, Efficacy Against Variants Being Tested: Dr Reddy's Official

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Sapra taking the first shot in Hyderabad.

South-africa , Hyderabad , Andhra-pradesh , India , United-kingdom , Russia , Russian , South-african , Bharat , Deepak-sapra , Serum-institute-covishield , Services-at-dr

First jab of Sputnik V Covid-19 vaccine administered; to cost around Rs 1,000 | India News

First doses of Sputnik V administered in India. Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy's Laboratories receives the first jab of the vaccine in Hyderabad. (ANI)
HYDERABAD: With the Sputnik V Covid-19 vaccine receiving clearance in India, Deepak Sapra, Global Head of Custom Pharma Services at Dr Reddy's Laboratories received the first jab of the vaccine in Hyderabad.
The first consignment of imported doses of Sputnik V vaccine landed in India on May 1 received regulatory clearance from the Central Drugs Laboratory at Kasauli in Himachal Pradesh on May 13.
As per a statement, imported doses of the Sputnik V Covid-19 vaccine are presently priced at Rs 948 (+5 per cent GST) per dose, with the possibility of a lower price point when local supply begins.

Hyderabad , Andhra-pradesh , India , Himachal-pradesh , Kasauli , Deepak-sapra , Central-drugs-laboratory-at-kasauli , Global-head , Custom-pharma-services , Central-drugs-laboratory , Ndia-news , Ndia-news-today

Working with regulators to bring one-dose Sputnik Light vaccine: Dr Reddy's Labs

UPDATED: May 15, 2021 01:35 IST
File photo of Russian single-dose Sputnik Light coronavirus vaccine (Photo Credits: Russian Direct Investment Fund via Reuters)
HIGHLIGHTS
Sputnik V will be more affordable once production begins in India: Deepak Sapra
DRDO's 2-DG drug for Covid patients will be much cheaper than alternatives, Sapra says
Russian-made Sputnik V coronavirus vaccine will only be available at select private hospitals, said Deepak Sapra, CEO (API and Services), Dr Reddy's Laboratories. The Hyderabad-based pharma giant has partnered with the Russian Direct Investment Fund (RDIF) to bring the adenoviral-based, two-dose vaccine to India.
In the first few days, Sputnik V will only be made available at select private hospitals in the country since the jab needs to be stored at -18 degrees Celsius.

India , Hyderabad , Andhra-pradesh , Russia , Kasauli , Himachal-pradesh , Russian , Deepak-sapra , Central-drugs-laboratory-in-kasauli , Russian-direct-investment-fund , Sputnik-light , India-today

Sputnik launched in Hyderabad at r₹r995 a dose

Sputnik launched in Hyderabad at r₹r995 a dose
Rhythma Kaul, Hindustan Times,New Delhi
© Provided by Hindustan Times
A medical specialist holds a vial of Sputnik V vaccine against the coronavirus in a department store in Moscow, Russia. (REUTERS)
On Friday, Dr Reddy’s Laboratories’s chief executive officer Deepak Sapra became the first person in the country to receive the Sputnik V vaccine developed by Russia’s Gamaleya Institute with assistance with the Russian sovereign wealth fund RDIF after it received emergency use authorisation in India on April 13.
DRL said in a statement that the jab marked the soft launch of the vaccine in the country. This is the first foreign-made Covid-19 vaccine to be used in India. The vaccine is priced at ₹995.40 per shot in the market, with the possibility of prices coming down further once local production starts.

Hindustan , India-general , India , Moscow , Moskva , Russia , Kasauli , Himachal-pradesh , Russian , Deepak-sapra , Stelis-biopharma , Central-drug-laboratory